Cullinan Associates Inc Novo Nordisk A S Transaction History
Cullinan Associates Inc
- $1.4 Billion
- Q1 2025
A detailed history of Cullinan Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Cullinan Associates Inc holds 8,675 shares of NVO stock, worth $620,262. This represents 0.04% of its overall portfolio holdings.
Number of Shares
8,675
Previous 8,675
-0.0%
Holding current value
$620,262
Previous $746,000
19.3%
% of portfolio
0.04%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.35 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.06 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$886 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$881 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$849 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $161B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...